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Abstract Promoter activity of protein kinase C (PKC) y gene 
was analysed by chloramphenicol acetyltransferase (CAT) assay 
using extracts from the cells transfeeted with various fusion con- 
structs containing the 5'-flanking region of the mouse PKC y 
gene and CAT gene. Transient expression experiments in PC12 
cells revealed that the upstream region of 87 bp from the tran- 
scriptional initiation site was sufficient for promoter activity. The 
region containing nueleotides 87 upstream from the transcrip- 
tional initiation site was shown to silence CAT activity in Balb/ 
c3T3 cells, in which mRNA of PKC 3' was not detected, suggest- 
ing that this region might contain a transcriptional regulatory 
element for the cell type-specific expression of the PKC 3' gene. 
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1. Introduction 
PKC, the major cellular receptor for diacylglycerol and 
tumor-promoting phorbol esters, has been implicated in the 
regulation of a variety of cell responses including membrane 
function, secretion of hormones and neurotransmitters, gene 
expression, and cell proliferation and differentiation. Recent 
biochemical experiments and molecular cloning have revealed 
that PKC consists of multiple subspecies [1,2]. These PKC 
subspecies show distinct expression patterns from one another. 
In particular, PKC y is distributed exclusively in the central 
nervous system [3]. Analysis of the promoter egion of PKC y 
is important for understanding the regulation of the tissue and 
cell type-specific expression of PKC y. Here we report the 
functional characterization of the mouse PKC y promoter. 
2. Materials and methods 
2.1. Library screening and DNA sequencing 
Two oligonucleotide primers were synthesized on the basis of rat 
PKC 7" cDNA [4]. The sense primer was 5'-GGCCATGGC(G/ 
T)GGTCTGGG(G/T)CC-3' (corresponding to numbers +237 to 
+257) and the antisense primer was 5'-CA(G/T)ATGAAGTC(A/ 
G)GT(A/G)CAGTG(A/G)CTGCA-3' (corresponding to numbers 
+386 to +412). PCR amplification was performed using these 
primers and mouse genomic DNA (30 cycles of 94°C for 1 min, 55°C 
for 2 min, and 72°C for 1 min). After amplification, a 190 bp DNA 
fragment was labeled by the random-oligolabelling reaction, then used 
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Abbreviations." bp, base pair(s); kb, kilobase(s); PCR, polymerase chain 
reaction. 
as a probe. A mouse genomic DNA library (Clontech Laboratories) 
was screened using nitrocellulose filters. Hybridization was carried out 
for 16 h at 42°C in 50% formamide, 5x SSPE (1 x SSPE: 180 mM 
NaCI, 10 mM sodium phosphate and 1 mM EDTA, pH 7.7), 5 x Den- 
hardt's olution (1 x Denhardt's solution: 0.02% polyvinylpyrolidone, 
0.02% Ficoll and 0.02% bovine serum albumin), 0.1% SDS, 100/~/ml 
heat-denatured salmon sperm DNA and the labeled probe. The filters 
were washed twice for 3 min at 25°C in 2 x SSC containing 0.1% SDS, 
and then twice for 15 min in 0.2 x SSC containing 0.1% SDS. The filters 
were autoradiographed onto Kodak X-AR films at - 80°C with inten- 
sifying screens. Nucleotide sequences were determined by the enzymatic 
chain termination method using Sequenase (USB). 
2.2. Northern blot analysis 
Total RNA was isolated according to the guanidinium isothiocya- 
nate/CsCl method [5] and then poly(A) ÷ RNA was purified by 
oligo(dT)-cellulose column chromatography (Pharmacia). The 
poly(A) + RNA (10 g/g) was electrophoresed on 1.5% agarose gel con- 
taining 16% formaldehyde and transferred to a nitrocellulose filter. A 
3.0 kbp EcoRI fragment containing rat PKC 7" eDNA labeled with 
[~-32P]dCTP was used as a probe. Hybridization and autoradiography 
were carried out as described above. 
2.3. Plasmid construction and CAT assay 
To construct the mouse PKC 7" promoter-CAT fusion plasmid, a 1.8 
kbp fragment of the mouse PKC y 5'-flanking region (- 1571 to + 234) 
was inserted at the HindlII site in pSV00CAT (Nippon gene) in both 
forward and reverse orientations, and named pRCAT1 and pRCATR, 
respectively. Several deletions of the 5'-flanking region of the mouse 
PKC 7" gene were generated using a Kilo-Sequencing Deletion Kit 
(Takara Shuzo). Fusion constructs were transfected into PC12 cells and 
Balb/c3T3 cells by Lipofectamine (Gibco BRL) and into C6 cells by 
Lipofectin (Gibco BRL). After incubation for 48-72 h, cells were har- 
vested and CAT activity was measured [6]. CAT enzyme reaction was 
performed at 37°C for 2 h using 0.25/tCi [14C]chloramphenicol, 5 mM 
acetyl-CoA and the cell extract. Acetylated reaction products were 
resolved by TLC analysis using a TLC plate (Merck) and a 95% CHC13/ 
5% methanol mobile phase, and then autoradiographed. As an internal 
control for differences in transfection efficiency, plasmid pTB 1328 con- 
taining the alkaline phosphatase gene was co-transfected [7]. Alkaline 
phosphatase activity in conditioned medium from the transfected cells 
was determined based on the increase in light absorbance at 405 nm 
which accompanies the hydrolysis ofp-nitrophenyl phosphate [8]. 
3. Results and discussion 
First, the expression of PKC y mRNA was examined in 
rodent cell lines. The transcripts were analyzed in a rat pheo- 
chromocytoma cell line PC 12, a non-neural cell line Balb/c3T3, 
and a glial cell line C6. As shown by Northern blot analysis in 
Fig. 1, about 3 kb o fPKC y mRNA was detected in PCI2 cells, 
whereas it was undetectable in both Balb/c3T3 and C6 cells. 
Therefore, PC12 cells were used as a cell line for analysis of the 
expression of the PKC 7 gene. 
Next, the 5'-flanking region of the mouse PKC 7 gene was 
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Fig. 1. Northern blot analysis of PKC y mRNA. Poly(A) + RNA from 
PC12, Balb/c3T3 and C6 cells (10/Jg each) was electrophoresed and 
hybridized consecutively with probes of rat PKC :y cDNA (A) and 
fl-actin (B). Lanes: l -- PC12; 2 = Balb/c3T3; 3= C6. 
cloned in order to identify the functional regulatory region of 
the mouse PKC 7/ gene. Nucleotide sequence analysis of the 
positive clone indicated that a 2 kbp EcoRI-Pst I  fragment con- 
tained the 5'-flanking region and the first exon of the mouse 
PKC y gene. As shown in Fig. 2, alignment of the sequences 
of mouse, rat and human revealed that the PKC :y 5'-flanking 
region demonstrated high homology among these three species. 
The transcriptional initiation site was mapped at the corre- 
sponding position to that of the rat PKC 7/gene [9] (data not 
shown). A search for canonical control sequences upstream 
from the transcriptional initiation site revealed that the region 
lacks classical control sequences, e.g. TATA and CAAT boxes, 
at the usual positions, - 25 to - 30 bp and - 50 to - 100 bp, 
respectively. Thus, there seemed to be other c/s-elements in this 
region interacting with transcriptional f ctors to initiate tran- 
scription. To search for potential binding sites for transcrip- 
tional factors, the 'SSCAN 33' computer program was used as 
described by Prestridge [10]. Together with the results of the 
nucleoprotein binding sites within the rat PKC 7 promoter 
region mapped by DNase I footprinting analysis in the previous 
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report [11], the mouse PKC y 5'-flanking region was indicated 
to possess ome candidates for the binding sites of transcrip- 
tional factors, including AP2 and SP1 as shown in Fig. 2. 
Chloramphenicol acetyltransferase (CAT) assay was per- 
formed in order to examine the functional promoter activity of 
the 5'-flanking region of the mouse PKC y gene. A reporting 
construct, containing the 1.8 kbp DNA fragment from - 1571 
to + 234, linked to the CAT-reporting ene (pRCAT1) was first 
investigated. As shown in Fig. 3, the extract from pRCAT1- 
transfected PC12 cells displayed positive CAT activity, whereas 
no activity was detected in the extracts from pRCATl-trans- 
fected Balb/c3T3 and C6 cells. These results indicate that the 
1.8 kbp DNA fragment contains the functional promoter, 
which is active in the cells expressing the PKC F gene. 
To characterize further the upstream sequences of PKC y 
that promote xpression of the CAT gene in a manner specific 
to cell types, a series of 5'-deletions of the 1.8 kbp PKC y 
promoter fragment were carried out (Fig. 4A). These shorter 
constructs were transfected into PC12 and Balb/c3T3 cells, and 
CAT assay was performed. As shown in Fig. 4B, the CAT 
activity did not change significantly, except for + 104/CAT plas- 
mid in PC12 cells. These results suggest hat the 5'-flanking 
region of 1.8 kbp of the mouse PKC 7/gene does not contain 
an apparent enhancer element, and that the short span of - 87 
bp upstream from the transcriptional initiation site is sufficient 
to support he transcriptional activity in this transient expres- 
sion assay. Some candidates for the binding sites of transcrip- 
tional factors were found in this short span as described above 
(Fig. 2). Therefore, these cis-elements might act as positive 
regulatory elements for the basal promoter activity of the PKC 
y gene. Furthermore, CAT activities in the extracts from Balb/ 
c3T3 cells transfected with - 1571 bp/CAT and - 196 bp/CAT 
were quite low. However, the activity with -87  bp/CAT con- 
struct was enhanced significantly (Fig. 4B, b, lane 4). These 
results uggest that a silencer-like element exists in this region 
Mouse  GATGACTGACTGAC . . . . . . .  TGGGAGAAAGGGGGTGGTCAAGGCTCGGAC9GACGTCCCCTCCTTGCATAGAGCCTC4~GGAATC43AAGTGTGCATGTGGAGAGGA . . . . .  G A~A 
Rat GATAACAGACTGGAATGTATTT~AGAAAGGGGGTGGACAAGGCTTGGAGGACGTCCCCTCCTTGCATAGAGCTC~AATGC4~AGTGTGCACGTGGAGAC-GA . . . . .  ~GGGGCA 
Human GATGACAGATTC42A . . . . . . .  GGGTGGTGGGC4~GGAG- -CCAGGCTCAGAGGATGCCCCTCCCTCCAGCCAGGCCCCCGGAGTGC4~TGTGTGCACGTGT~GGGCAGGGAGGACA 
GAT AC GA TG GG G GGGGG G C AGC42T GAGGA G CCC CCT GC G A TGG GTGTGCA GTG G GG GG GG CA 
~1 ~2 
Mouse  TCTGTCCCGG-  . . . . . . .  G . . . . .  CGG~GC4~TTTAAACTGAAACCCC~COCCTTGGTCGTCATGGCAACGCCTTCC~CJ~XXX~GA~TTCTACATTTCAGCAGGTGCTGAGA 
Rat ACTGTCCGGGATTCTTGGG . . . . .  GGT~AACGCCTTTAAACTGAAACCC(7QGOCCTTGGTGCTCATGGCAA-GCCTA~GACTTCTAC-TTTCAGCAGGTGCGATAG 
Human TTTGTCCCGT . . . . . . . .  GTCTCC~AGGGGAGCGCCTTTAAGCCGAAA~TCT~GGTCGTCCTG-CAA-CC4~CTCCCCC&CC~C~C~CTCCCACATTTCAGCAGGTGCCGGAG 
TGTCC G G G CK97_4~ G CTTTAA C GAAACCC CC CT  GGT TC TG CAA C CCCCCACCC G CT  C AC TTTCAGCAGGTGC 
~2 
Mouse  GC GAACGTCCC - - -~CCGCCGCCCGTGCCTGCGC4~ TCCTTGATGCCCCAC-CC TTC-  - -AGC TCTG-  -ACCCC&C~g~.~CTTTCTCCCC - GGTCGGT GCT GCCCGTGCC GGGGTGT-  - TGCT 
Rat C - - GACGTCCC - - - GCCGCCGCCCGTGCCTGCCG-  TCCTAGATGCCCCAGTCT CTACTGCTCTG-  - A~A- -  _OC¢~CTTTCTCCCG- GCTCGGTACAGCTGGTGCC~TGCTC4~T 
Human CTGGAGC TCCCACCGCCGCCGCCCGTGCCTCCGC42T GCCGGC-  GCCCCTGCCTTT - - - C-C4~ TCTTCCTCCCCACTC GCCCGCTCCCCCTGCYCGGAGCC~ C4~C~CC GGGGTGC-  CGCT 
A TCCC GCCGCCGCCCGTGCCT C G T C G GCCCC G CTT  GCTCT CCCCAC CGC CTCCC CGG C G CCGGC4~+G GCT 
-119 
-12 
+98 
Mouse  TTCTGCCGTGTGC-•TGTC9CACCGTTAGGTGCCTTGCCCCTGTCCTTCCTATCTCAGAGTCTC,CGGAGT-CCTCCTACCG . . . . . . . . . . . . . . . . . . . . . . . .  CCGTCCACCTGTTTCC 
Rat TTCTGCCCTGCGC- -TGCGCACCGTTAG-TGCCCTGCCCCTGTCCTTCCGATCTCAGAGTCTGCGGAGTGGCCCCTATCG . . . . . . . . . . . . . . . . . . . . . . . .  CCGTCCACCTGTTTCC 
Human CCCTGCCT~GCGCTCCGCACCTGGAGGTGCCTTGCCCCTCTCCTGCCCACCTCGGAATTTCCCTGTG-GCTCCTTTGATCCTTCGAGTCTCCAGCTCCTCTCCCTTCCACCTGTTTCC 
CTGCC G GC T GCACC AG TGCC TGCCCCT TCCT CC A CTC GA T T C C CCT CC TCCACCTGTTTCC 
+191 
Mouse  TC-GGAAAAAGGCCAGCTCGTGATCCCTTCTGCGTTCCT~CATG +238 
Rat TCAGAAAAAAGGCCAGCTCGTGATCCCTGCTGCGTTCCT~CATG 
Human CC-CAAGAAAGGCAGGATCCTGGTCCCTGCTACGTTTCTGGCKS4~CATG 
C A AAAGGC G TC TG TCCCT CT CGTT CT~CATG 
Fig. 2. Alignment of the nucleotide sequence ofthe mouse, rat and human PKC y 5'-flanking region. The nucleotide number indicated for the mouse 
sequence is relative to the transcriptional initiation site denoted by an asterisk. Gaps introduced to maximize homology are shown as dashes. 
Translational initiation codon ATGs are underlined. SP1 and AP2 binding sequences are denoted by italics. The consensus sequence d rived is shown 
at the bottom. The nucleotide sequence ofthe 5'-flanking region of the mouse PKC y gene from the clone isolated in this study was exactly the same 
as that registered in GeneBank under accession number X65720. Rat and human sequences were from [9] and GeneBank accession number X62533, 
respectively. 
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Fig. 3. CAT activity in the extracts of PC12, Balb/c3T3 and C6 cells 
transfected with the PKC y promoter-CAT fusion genes. CAT assay 
was performed on transient transfectants generated in PC12 (A), Balb/ 
c3T3 (B) and C6 (C). Lanes: 1 = pSV2CAT plasmid; 2 = pRCAT1 
plasmid; 3 = pRCATR plasmid; 4 -- pSV00CAT plasmid. Essentially 
identical results were obtained in five independent experiments. 
upstream from - 87, and that expression of the PKC 7/gene is 
regulated negatively in most types of cells except for neuronal 
cells. 
The transcriptional regulation of many eukaryotic genes has 
been intensively studied during the last two decades, and tissue- 
specific enhancers and silencers have been identified. Tissue- 
specific enhancer elements for different cell types, e.g. liver [12], 
lymphoid cells [13], pancreas [14], and anterior pituitary [15] are 
well established. In addition, several silencer elements to regu- 
late neuronal cell-specific expression were previously identified 
as follows; (i) the sequence from - 60 to - 34 in the rat type II 
sodium channel [16,17]; (ii) from - 163 to - 154 and - 72 to - 62 
in rat peripherin [18]; (iii) from -73  to -62  in the mouse 
A. 
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Fig. 4. Deletion analysis of the PKC y promoter egion. PC12 and 
Balb/c3T3 cells were transiently transfected with PKC y promoter- 
CAT fusion genes. (A) Schematic representation of the 5'-deletion 
DNAs. Numbers indicate the correspondence with the lanes of CAT 
assay. (B) CAT activity with the 5'-deletion DNAs in PC12 (a) and 
Balb/c3T3 (b). Lanes: 1 = pSV2CAT plasmid; 2 = pRCAT1 plasmid 
(- 1571 to +234); 3 =-  196/CAT plasmid (- 196 to +234); 
4=-87/CAT plasmid (-87 to +234); 5=+104/CAT plasmid 
(+ 104 to +234); 6 = pSV00CAT plasmid. Essentially identical results 
were obtained in three independent experiments. 
neurofilament [19]; (iv) from - 231 to - 211 in the human syn- 
apsin I gene [20]; (v) from - 400 to - 388 in the human dopam- 
ine fl-hydroxylase; (vi) from - 1014 to - 1002 in the rat type II 
sodium channel; and (vii) from -1479 to -1471 in the rat 
SCG10. (i)-(iii) include a region that contains CCAGG,  5 bp 
common core sequence [21]. (iv) has a homologous equence 
to (i) [22]. (v) has a silencer element homologous to (vi) and (vii) 
[23]. The sequence from - 1571 to +234 bp of the mouse PKC 
y gene contained neither the 5 bp CCAGG common core se- 
quence nor another stretch homologous to the sequence men- 
tioned above (iv)-(vii). Thus, a new type of repressive lement 
might contribute to the neuron-specific expression of the PKC 
y gene. Future studies, such as the precise structural analysis 
and identification of the trans-acting factors that interact with 
this element, are needed in order to elucidate the mechanism 
of the neuronal cell type-specific expression of the PKC y gene. 
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